Records real-world results of a heat-based device used in brain surgery for movement disorders
Collects outcomes of radiofrequency ablation devices in people with Parkinson disease, dystonia, or tremor.
Key facts
- Who runs it
- Boston Scientific Corporation
- Where
- London, United KingdomSee the siteAlso in 1 other country, 3 sites
- Trial code
- Registry title
- Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 29 Jan 2024
- Expected to end
- Dec 2035
- Type of study
- Observational
- Treatments tested
- Radiofrequency Ablation
- Record updated
- 13 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who are scheduled to have treatment with a commercially approved Boston Scientific radiofrequency (RF) ablation system for pain or for brain and nervous system conditions.
- Sex
- All sexes can join.
- Earlier treatment
- The person must be scheduled to be treated with a commercially approved Boston Scientific RF system, as set out in its local Directions for Use.
Main reasons for not taking part
- Has any contraindication listed in the local Directions for Use
- Has a cognitive impairment or another characteristic that limits the ability to assess pain relief
- Cannot complete the study assessments
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU)
- Signed a valid, IRB/EC/REB-approved informed consent form
Who cannot take part
- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
- Meets any contraindications per locally applicable Directions for Use (DFU)
Where in United Kingdom
Also in 1 other country, 3 sites
- St Georges HospitalLondon, United KingdomContact: Boston Scientific Clinical ResearchTaking people
About the trial
What the trial wants to find out
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
The group in the trial
- Boston Scientific Radiofrequency Ablation Systems
Subjects treated with Boston Scientific commercially approved radiofrequency (RF) ablation systems in the central nervous system (CNS).
Treatment: Radiofrequency Ablation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System
- Plain-language title
- Records real-world results of a heat-based device used in brain surgery for movement disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 13 October 2026